Prefer a daily pill over injections
However, patients must follow a comprehensive treatment plan that includes lifestyle modifications and regular monitoring to ensure the best possible results and minimize potential risks
Frequent small meals, not large ones
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an East Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
The slow response time, lack of customer support, and confusing communication just dont make it worth itespecially when there are better, more personalized options available
All we're proposing to clinicians is Hey, think about the patients who are at risk and have a strategy to monitor and mitigate that risk. What about patients on GLP-1s